Navigation Links
Combination growth factors for Stem cell proliferation

Professor Harvey Lodish and his post-doc Chengcheng Zhang from Whitehead Institute for Biomedical Research in Cambridge have found a combination of growth factors// which enriches and increases the number of stem cells in the laboratory before it could be injected into the recipient.

Stem cell therapy as shown that the quantity of stem cells required for a therapy is very high and it requires isolating large number of stem cells. Stem cells for therapeutic treatment are isolated from various sources like bone marrow, cord blood and peripheral blood but the quantity of isolated stem cells are very less.

Hematopoietic stem cells are required for production of billions of new blood cells and immune cells every day in our body as these cells have the capacity to give rise to different blood cells which protects the body from infection. Hematopoietic stem cells are used for treating various blood disorders and blood cancers.

The researchers combined the already well established growth factor IGF-2 with Angiopoietin-like 2 and -3 and found that the new combination increased the production of hematopoietic cell in the lab by more than 30 times. The researchers feel that increased production of stem cells would increase the transplantation rate and would also help in gene targeted therapy in which the gene of interest could be injected into the vector virus and these stem cells can be proliferated in the lab by using this combination growth factors and transferred to the recipient as the probability of gene transfer would be effectively increased. Though the combination growth factors have been very effective in proliferation in the laboratory conditions the researchers have to see the effect of this proliferation in humans. The result of the work has been published in the Journal Nature Medicine.
'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston ... east Texas, is launching a regional charity effort to provide publicity assistance and ... Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based ... area, is spearheading a regional charity campaign organized to provide support to Christina Upchurch ... of this year, Christina and her children returned from out of town to find ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the ... efforts with its product now available through Jet.com. , After 25 years of ... powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 AccuGenomics, Inc., a diagnostic company ... announced that the company has provided an AccuKit to ... Carolina at Chapel Hill and to Qura Therapeutics for ... and quantify HIV reservoir and viral expression in human ... HIV Cure Center is a joint initiative between the ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: